Pharma in Spotlight as Pandemic Continues in 2021

The new year began with a continued surge in illness and deaths due to COVID-19, along with high hopes for combatting the virus with effective vaccines and therapies. Strong efficacy data and reassuring safety reports indicate that new vaccines may prevent contamination, thus shifting the focus to the monumental task of producing, packaging, shipping, and administering millions of doses as quickly and effectively as possible. The success of biopharmaceutical manufacturers in developing and testing a whole new type of vaccine in less than a year reflects the scientific and technological strength of the industry and the research community, bolstered by critical financial and...